REQUEST A DEMO
Total
USD $0.00
Search more companies

Tak Pharma Sp. z o.o. (Poland)

Main Activities: Wholesale Trade Agents and Brokers
Full name: Tak Pharma Sp. z o.o. Profile Updated: April 08, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English & Polish Download a sample report

Tak Pharma Sp. z o.o. is an enterprise in Poland, with the main office in Warsaw. It operates in the Wholesale Trade Agents and Brokers industry. It was first established on October 21, 2004. It currently has a total number of 21 - 50 (2009) employees. From the latest financial highlights, Tak Pharma Sp. z o.o. reported a net sales revenue increase of 29.84% in 2023. During that time, Tak Pharma Sp. z o.o.’s total assets grew by 4.94%. The net profit margin of Tak Pharma Sp. z o.o. decreased by 9.09% in 2023.

Headquarters
Ul. Al. Wojska Polskiego 27/14
Warsaw; Mazowieckie; Postal Code: 01-515

Contact Details: Purchase the Tak Pharma Sp. z o.o. report to view the information.

Basic Information
Total Employees:
Purchase the Tak Pharma Sp. z o.o. report to view the information.
Outstanding Shares:
Purchase the Tak Pharma Sp. z o.o. report to view the information.
Registered Capital:
Purchase the Tak Pharma Sp. z o.o. report to view the information.
Incorporation Date:
October 21, 2004
Key Executives
Purchase this report to view the information.
President
Purchase this report to view the information.
Vice President
Purchase this report to view the information.
Proxy
Ownership Details
Purchase this report to view the information.
91%
Company Performance
Financial values in the chart are available after Tak Pharma Sp. z o.o. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency PLN. Absolute financial data is included in the purchased report.
Net sales revenue
29.84%
Total operating revenue
19.6%
Operating profit (EBIT)
14.25%
EBITDA
12.96%
Net Profit (Loss) for the Period
4.5%
Total assets
4.94%
Total equity
4.26%
Operating Profit Margin (ROS)
-4.43%
Net Profit Margin
-9.09%
Return on Equity (ROE)
0.02%
Quick Ratio
-0.28%
Cash Ratio
-0.06%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?